LUYAN PHARMA CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.02 CNY | -0.22% |
|
+1.92% | +0.33% |
| Apr. 15 | Luyan Pharma Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 2023 | Luyan Pharma Co.,Ltd. Announces Board Appointments | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2022 | 19.46B 2.69B | Sales 2023 | 19.85B 2.75B | Capitalization | 3.49B 484M |
|---|---|---|---|---|---|
| Net income 2022 | 345M 47.76M | Net income 2023 | 364M 50.39M | EV / Sales 2022 | 0.4 x |
| Net Debt 2022 | 4.49B 621M | Net Debt 2023 | 4.25B 589M | EV / Sales 2023 | 0.39 x |
| P/E ratio 2022 |
9.36
x | P/E ratio 2023 |
9.56
x | Employees | 5,475 |
| Yield 2022 |
3.6% | Yield 2023 |
3.34% | Free-Float | 57.22% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.22% | ||
| 1 week | +1.92% | ||
| Current month | +1.92% | ||
| 1 month | +8.28% | ||
| 3 months | +35.64% | ||
| 6 months | -4.95% | ||
| Current year | +0.33% |
1 week
8.85
9.12
1 month
7.909.12
Current year
6.109.30
1 year
6.1010.38
3 years
6.1010.68
5 years
6.1012.02
10 years
6.1032.11
| Managers | Title | Age | Since |
|---|---|---|---|
Jin Xiang Wu
CEO | Chief Executive Officer | 62 | 08-08-31 |
Cong Jin Yang
DFI | Director of Finance/CFO | 55 | 11-10-19 |
Cui Ping Li
BRD | Director/Board Member | 44 | 11-10-19 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Zhi Yang Lin
BRD | Director/Board Member | 68 | 17-10-18 |
Jin Xiang Wu
CEO | Chief Executive Officer | 62 | 08-08-31 |
Yan Zhao Tang
BRD | Director/Board Member | 56 | 17-10-18 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-08 | 9.02 | -0.22% | 4,974,951 |
| 24-05-07 | 9.04 | -0.33% | 5,009,548 |
| 24-05-06 | 9.07 | +2.49% | 6,857,588 |
| 24-04-30 | 8.85 | +1.61% | 6,354,276 |
End-of-day quote Shenzhen S.E., May 07, 2024
More quotes
Luyan Pharma Co., Ltd., formerly LUYAN (FUJIAN) PHARMA CO., LTD. is principally engaged in the distribution and pharmaceutical retail chain business of medicine, Chinese herbal medicine, medical instrument and the second type vaccine. The Company makes Fujian Province as its major target market and provides its products directly to medical institutions at all levels.
Sector
Pharmaceuticals
Calendar
2024-08-19
- Q2 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +0.33% | 487M | |
| +17.42% | 71.72B | |
| -3.33% | 24.29B | |
| +7.71% | 8.31B | |
| -19.61% | 8.22B | |
| +1.47% | 8.16B | |
| +5.56% | 4.76B | |
| +15.41% | 4.31B | |
| -0.87% | 4.1B | |
| +23.20% | 3.78B |
- Stock Market
- Equities
- 002788 Stock